<bill session="117" type="s" number="288" updated="2023-01-11T13:46:37Z">
  <state datetime="2021-02-08">REFERRED</state>
  <status>
    <introduced datetime="2021-02-08"/>
  </status>
  <introduced datetime="2021-02-08"/>
  <titles>
    <title type="display">TRANSPLANT Act of 2021</title>
    <title type="official" as="introduced">A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.</title>
    <title type="short" as="introduced">Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021</title>
    <title type="short" as="introduced">TRANSPLANT Act of 2021</title>
  </titles>
  <sponsor bioguide_id="R000122"/>
  <cosponsors>
    <cosponsor bioguide_id="B001135" joined="2021-02-08"/>
    <cosponsor bioguide_id="D000622" joined="2021-04-13"/>
    <cosponsor bioguide_id="S001184" joined="2021-02-08"/>
    <cosponsor bioguide_id="S001203" joined="2021-02-08"/>
  </cosponsors>
  <actions>
    <action datetime="2021-02-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-02-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S575" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="941" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Blood and blood diseases"/>
    <term name="Cell biology and embryology"/>
    <term name="Congressional oversight"/>
    <term name="Government studies and investigations"/>
    <term name="Health programs administration and funding"/>
    <term name="Medical research"/>
    <term name="Organ and tissue donation and transplantation"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2021-05-10T21:18:28Z" status="Introduced in Senate">Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.</summary>
</bill>
